Skip to main content
S
StopMyCancer
Cancer Types Navigate Stories Access & Equity Translator Tool About
English Español Français
Cancer Types Navigate Stories Access & Equity Pathology Translator About
Language
EN ES FR
Home / Cancer Types / Esophageal Cancer

Esophageal Cancer

Understanding cancer of the esophagus. Types, risk factors, diagnosis, staging, and treatment approaches.

Esophageal cancer is cancer of the tube that carries food from your mouth to your stomach. There are two main types: squamous cell carcinoma and adenocarcinoma. Most cases are diagnosed at advanced stages, making it a serious disease requiring multimodal treatment.

What Is Esophageal Cancer?

The esophagus is a muscular tube about 10 inches long. Cancer typically starts in the inner lining and can grow inward and outward, affecting swallowing and nutrition.

Key fact: Esophageal cancer is often diagnosed late because early symptoms are subtle. By the time patients seek care, cancer has often invaded deeper layers.

Types

  • Squamous cell carcinoma (SCC): Arises from the flat cells lining the upper and middle esophagus. Associated with tobacco and alcohol.
  • Adenocarcinoma: Arises from glandular cells in the lower esophagus. Associated with acid reflux (GERD) and Barrett's esophagus.

Risk Factors

  • Tobacco use: Smoking significantly increases SCC risk.
  • Alcohol: Heavy drinking increases SCC risk, especially combined with tobacco.
  • Acid reflux (GERD): Chronic reflux increases adenocarcinoma risk.
  • Barrett's esophagus: Precancerous condition where reflux damages the lining. High-grade dysplasia has significant cancer risk.
  • Obesity: Increases GERD and adenocarcinoma risk.
  • Diet: Low fruit/vegetable intake increases risk.
  • Age: Usually 60+.

Symptoms

  • Difficulty swallowing (dysphagia), especially solid foods initially
  • Chest pain or discomfort when swallowing
  • Unintentional weight loss
  • Heartburn or persistent acid reflux
  • Vomiting
  • Hoarseness (if tumor affects nearby nerves)
  • Cough or choking sensation

Important: Difficulty swallowing that persists for more than 2 weeks warrants investigation.

Diagnosis

Diagnostic tools:

  • Upper endoscopy (EGD): Camera down throat to visualize tumor and take biopsy.
  • Biopsy: Tissue sample for pathology confirmation.
  • CT/MRI: Assess tumor extent and lymph node involvement.
  • PET scan: Identifies metastatic disease.
  • Endoscopic ultrasound (EUS): Ultrasound probe down throat to assess depth of invasion.

Staging

Uses TNM system (Tumor, Nodes, Metastasis):

  • Stage I: Early tumors confined to mucosa/submucosa, no node involvement.
  • Stage II-III: Tumors invading muscle layers, with lymph node involvement.
  • Stage IV: Metastatic disease (distant spread).

Most esophageal cancers are stage III-IV at diagnosis.

Treatment Options

Endoscopic Therapy (Early Stage)

For very early cancers (stage I), endoscopic mucosal resection or ablation may be curative.

Neoadjuvant Chemotherapy & Radiation

Given before surgery to shrink tumor and improve resection outcomes. 5-FU/cisplatin is standard chemotherapy. Improves survival compared to surgery alone.

Esophagectomy (Surgery)

Removing the cancerous esophagus and surrounding lymph nodes. Stomach is pulled up to replace the esophagus. Major surgery with significant recovery time.

Chemoradiation (Definitive Treatment)

For patients not surgical candidates, concurrent chemotherapy and radiation can provide cure or long-term control. 5-FU/cisplatin with radiation therapy.

Immunotherapy

Checkpoint inhibitors (nivolumab, pembrolizumab) approved for advanced/metastatic esophageal cancer. Increasingly used in combination with chemotherapy.

Side Effects & Survivorship

After esophagectomy: Difficulty swallowing, reflux, dumping syndrome (rapid gastric emptying), nutritional deficiencies, fatigue.

During chemoradiation: Severe mouth sores, difficulty swallowing, nausea, fatigue, skin irritation.

Long-term: Many survivors have chronic swallowing difficulty and require dietary modifications. Nutritional monitoring is crucial.

Prognosis

Esophageal cancer has a serious prognosis because it's usually diagnosed late.

  • Stage I: 40-50% 5-year survival with endoscopic therapy or surgery.
  • Stage III: With neoadjuvant chemoradiation and surgery, 30-40% 5-year survival.
  • Stage IV: Median survival 8-12 months with chemotherapy or immunotherapy.

Seek Immediate Care If You Experience:

  • Complete inability to swallow (even saliva)
  • Vomiting blood
  • Severe chest pain
  • Difficulty breathing

Key Questions for Your Doctor

  • What is my stage and what does that mean for treatment?
  • Am I a candidate for surgery, and what does esophagectomy entail?
  • What is the benefit of neoadjuvant chemotherapy and radiation?
  • Are immunotherapy options available?
  • What nutritional support will I need?
  • What swallowing rehabilitation is available?
  • Are there clinical trials I should consider?

StopMyCancer

Your cancer. Explained. Supported. Navigated.

Navigation

  • Cancer Types
  • Navigate
  • Stories
  • Access & Equity

Resources

  • Pathology Translator
  • About
  • GitHub

© 2025 StopMyCancer. Licensed under CC BY 4.0.